Quick Answer
VACCINEX, INC. reported Total Assets of $2.60 million for fiscal year 2024.
VACCINEX, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $2.60M | -28.5% |
| 2023 | $3.63M | -54.5% |
| 2022 | $7.98M | -19.0% |
| 2021 | $9.84M | -15.9% |
| 2020 | $11.70M | +154.2% |
| 2019 | $4.60M | -79.1% |
| 2018 | $22.03M | +295.1% |
| 2017 | $5.58M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $4.85M | +89.8% | +105.1% |
| June 30, 2024 | $2.37M | -23.3% | -67.9% |
| March 31, 2024 | $7.37M | +50.5% | +102.9% |
| December 31, 2023 | $3.63M | -54.5% | +41.9% |
| September 30, 2023 | $2.56M | -70.3% | -17.1% |
| June 30, 2023 | $3.08M | -75.5% | -37.0% |
| March 31, 2023 | $4.89M | -73.0% | -38.6% |
| December 31, 2022 | $7.98M | -19.0% | -7.4% |
- VACCINEX, INC. showed a decrease of -28.5% in Total Assets compared to the prior fiscal year.
- Over the 2017–2024 period, VACCINEX, INC.’s total assets has declined by 53.4% (from $5.58 million to $2.60 million).
- The most recent figure is from VACCINEX, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: